The significant EPS miss and continued losses are the dominant signals for a $23M market cap stock, overriding the positive operational narrative. Monitor for any future dilution or cash burn updates, as the path to profitability remains distant.
Price Chart
Executive Summary
Cosmos Health reported Q2 2026 revenue of $18.99M (+28.8% YoY), but EPS of -$0.10 missed the consensus estimate of -$0.05 by 100%. The company highlighted record revenue, debt reduction, and a strengthened balance sheet, but the significant EPS miss and ongoing losses are the primary financial outcomes for the quarter.
Key Financial Metrics
Key Facts
- Q2 2026 revenue was $18.99M, a 28.8% YoY increase.
- EPS of -$0.10 missed the consensus estimate of -$0.05 by 100%.
- H1 2026 revenue was $36.91M, up 29.7% YoY.
- The company retired an $8M convertible note 12 months early, eliminating future dilution from that instrument.
- 5.1M+ shares were repurchased for ~$1.11M under a $5M buyback program.
- The company reaffirmed 2026 guidance of >$90M revenue and 2029 guidance of $200.6M revenue.
Financial Impact
EPS miss of 100% on a -$0.05 consensus, with revenue slightly above the $20.9M consensus but not disclosed as a beat. The company is still generating losses.
Risk Factors
- Continued operating losses and negative EPS despite revenue growth.
- Low market cap ($23M) and poor historical post-filing stock performance.
- Execution risk on ambitious 2029 revenue guidance of $200.6M.
- Potential need for future capital raises if cash burn does not improve.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3356008 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.2530 | awaiting T+20 | — | $0.2626 (+3.79%) |
Oct 16, 2026 9d ago | SC 13G/A | $0.3250 | awaiting T+20 | — | $0.2626 (−19.20%) |
Oct 9, 2026 16d ago | 8-K | $0.3496 | awaiting T+20 | — | $0.2626 (−24.89%) |
Sep 3, 2026 7w ago | Press Release | $0.2660 $0.4300 | ▼ −61.65% | ▼ −62.77% | $0.2626 (+1.28%) |
Aug 19, 2026 9w ago | Press Release | $0.1930 | awaiting T+20 | — | $0.2626 (−36.06%) |
Jul 20, 2026 13w ago | Press Release | $0.2303 $0.2050 | ▼ −10.99% | ▼ −15.11% | $0.2626 (+14.03%) |
Jul 17, 2026 14w ago | Press Release | $0.2348 $0.2179 | ▼ −7.20% | ▼ −11.64% | $0.2626 (+11.84%) |
Jul 16, 2026 14w ago | Press Release | $0.2807 $0.2065 | ▼ −26.43% | ▼ −30.05% | $0.2626 (−6.45%) |
Jul 15, 2026 14w ago | Press Release | $0.2785 $0.2071 | ▼ −25.64% | ▼ −27.98% | $0.2626 (−5.71%) |
Jul 14, 2026 14w ago | Press Release | $0.3071 $0.2198 | ▼ −28.43% | ▼ −30.92% | $0.2626 (−14.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers